Clinical Trial Update: A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Raptiva in combination with topical psoriasis therapies has completed in psoriasis patients. The update confirms trial completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Psoriasis | Phase 4 | Status: COMPLETED